G Albrand
Overview
Explore the profile of G Albrand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mongiat-Artus P, Paillaud E, Albrand G, Neuzillet Y
Prog Urol
. 2019 Nov;
29(14):896-897.
PMID: 31771771
No abstract available.
2.
Neuzillet Y, Albrand G, Caillet P, Paillaud E, Mongiat-Artus P
Prog Urol
. 2019 Nov;
29(14):874-895.
PMID: 31771770
Aim: To define the necessary arrangements of medical treatment with anti-angiogenics, mTOR inhibitor or systemic immunotherapies in the management of metastatic renal cell carcinoma in elderly patients. Method: Bibliographical search...
3.
Mongiat-Artus P, Paillaud E, Caillet P, Albrand G, Neuzillet Y
Prog Urol
. 2019 Nov;
29(14):865-873.
PMID: 31771769
Purpose: To describe the epidemiology of renal cell carcinoma (RCC) and its natural history in the elderly patient. To propose adaptations of geriatric evaluation specific to RCC. Recall therapeutic options...
4.
Mongiat-Artus P, Paillaud E, Caillet P, Albrand G, Neuzillet Y
Prog Urol
. 2019 Nov;
29(14):828-839.
PMID: 31771767
Purpose: To describe the epidemiology of prostate cancer (PCa) and its natural history in the elderly patient. To propose adaptations of geriatric evaluation specific to PCa. Recall therapeutic options and...
5.
Mongiat-Artus P, Paillaud E, Albrand G, Caillet P, Neuzillet Y
Prog Urol
. 2019 Nov;
29(14):807-827.
PMID: 31771766
Purpose: To explain the notion of frailty, then to explain how crucial is the detection of frailty detection in the elderly patient, and, in cases of suspected frailty, how crucial...
6.
Mongiat-Artus P, Paillaud E, Albrand G, Neuzillet Y
Prog Urol
. 2019 Nov;
29(14):797-806.
PMID: 31771765
Purpose: First, to present the epidemiological data of aging and of cancers and to describe the respectives expected evolutions. Second, to present biological and genetic data on aging and on...
7.
Mongiat-Artus P, Paillaud E, Albrand G, Neuzillet Y
Prog Urol
. 2019 Nov;
29(14):795-796.
PMID: 31771764
No abstract available.
8.
Tricard T, Tsoumakidou G, Lindner V, Garnon J, Albrand G, Cathelineau X, et al.
Prog Urol
. 2017 Sep;
27(15):926-951.
PMID: 28869173
Background: Ablative therapies (AT) in kidney cancer are rising. It's important to evaluate the situation of this therapy. The aim of this study is to identify the best indications for...
9.
Albrand G, Mottet N, Ruffion A, Flechon A, Bensadoun R, Gigante M, et al.
Prog Urol
. 2012 Oct;
22 Suppl 2:S55-63.
PMID: 23098791
Managing an elderly subject with prostate cancer brings into play the notion of likelihood of survival before any diagnostic or therapeutic decision can be made. The diagnostic strategy must be...
10.
Maure S, Albrand G, Amra C
Appl Opt
. 2010 Dec;
35(28):5573-82.
PMID: 21127560
We investigate the origin of low-level scattering from high-quality coatings produced by ion-assisted deposition and ion plating. For this purpose we use the polarization ratio of light scattering to separate...